Ensign Peak Advisors, Inc In8 Bio, Inc. Transaction History
Ensign Peak Advisors, Inc
- $56.1 Billion
- Q3 2024
A detailed history of Ensign Peak Advisors, Inc transactions in In8 Bio, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 829,176 shares of INAB stock, worth $207,294. This represents 0.0% of its overall portfolio holdings.
Number of Shares
829,176
Previous 1,118,266
25.85%
Holding current value
$207,294
Previous $950,000
76.53%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding INAB
# of Institutions
27Shares Held
7.62MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD1.67MShares$418,6590.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$355,9740.0% of portfolio
-
683 Capital Management, LLC New York, NY1.35MShares$337,5760.03% of portfolio
-
Sigma Planning Corp Ann Arbor, MI851KShares$212,8200.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL435KShares$108,7020.0% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $6.13M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...